CE Activities
Treatments for Age-Related Macular Degeneration (AMD) –58-Year-Old Female with Hypertension, Hyperlipidemia, and Long-term Smoking History
December 12, 2023FEATURING: Ryan Bitton, PharmD, MBA, Adrienne W. Scott, MD
Risk of Retinal Vein Occlusion (RVO) –52-Year-Old Male with a History of Poor Adherence to Hypertension and Dyslipidemia Therapy
December 12, 2023FEATURING: Jordan Graff, MD, FACS, Dana McCormick, RPh, FAMCP
Retinopathy of Prematurity (ROP) –Management of an Infant Born at 30 Weeks Gestational Age in a Rural Area
December 12, 2023FEATURING: Jeffrey Dunn, PharmD, MBA, Edward H. Wood, MD
PayerTalkCE™Presents: Impact of An Aging US Population on Retinal Diseases
December 12, 2023FEATURING: Garvin H. Davis, MD, Jeffrey Dunn, PharmD, MBA
PayerTalkCE™ Presents: Innovations in the Retinal Disease Treatment Paradigm
October 3, 2023FEATURING: Ferhina S. Ali, MD, MPH, FASRS, Steven S. Kheloussi, PharmD, MBA, FAMCP
PayerTalkCE™ Presents: Major Advances in the Management of Retinopathy of Prematurity (ROP)
October 2, 2023FEATURING: Jeffrey Dunn, PharmD, MBA, Edward H. Wood, MD
PayerTalkCE presents: Unmet Needs in AMD and DME
September 27, 2023FEATURING: Steven S. Kheloussi, PharmD, MBA, FAMCP, Jordan M. Graff, MD, FACS
Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations Managed Care Pathway for Better Management of Retinal Vein Occlusion (RVO)
January 31, 2023EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA
Facilitating Optimal Outcomes for the Management of Retinal Diseases: Health Plan Best Practice Recommendations: Managed Care Pathway for Better Management of Age-related Macular Degeneration (AMD)
January 31, 2023EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA
Facilitating Optimal Outcomes for the Management of Retinal Diseases:Health Plan Best Practice RecommendationsManaged Care Pathway for Better Management of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)
January 3, 2023EXPERT FACULTY: Jeffrey Dunn, PharmD, MBA, Matt White, JD